{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:08:28Z","timestamp":1763017708689},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/bmt.2016.321","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T15:06:22Z","timestamp":1483974382000},"page":"609-611","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Persistent recipient-derived human adenovirus (HAdV)"],"prefix":"10.1038","volume":"52","author":[{"given":"R E","family":"Schultze-Florey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"K\u00fchnau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Heim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Eiz-Vesper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Maecker-Kolhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"BFbmt2016321_CR1","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1128\/JVI.76.21.10608-10616.2002","volume":"76","author":"CT Garnett","year":"2002","unstructured":"Garnett CT, Erdman D, Xu W, Gooding LR . Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 2002; 76: 10608\u201310616.","journal-title":"J Virol"},{"key":"BFbmt2016321_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/tid.12022","volume":"14","author":"S Matthes-Martin","year":"2012","unstructured":"Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis 2012; 14: 555\u2013563.","journal-title":"Transpl Infect Dis"},{"key":"BFbmt2016321_CR3","doi-asserted-by":"crossref","unstructured":"Kosulin K, Geiger E, V\u00e9csei A, Huber W, Rauch M, Brenner E et al. Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clin Microbiol Infect 2016; 22: 381.e1\u2013381.e8.","DOI":"10.1016\/j.cmi.2015.12.013"},{"key":"BFbmt2016321_CR4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","volume":"100","author":"S Chakrabarti","year":"2002","unstructured":"Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002; 100: 1619\u20131627.","journal-title":"Blood"},{"key":"BFbmt2016321_CR5","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.72.3.2388-2397.1998","volume":"72","author":"O Farace","year":"1998","unstructured":"Farace O, Godfrin D, Gaston J, Lengagne RE, Tursz T, Boulanger P . Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol 1998; 72: 2388\u20132397.","journal-title":"J Virol"},{"key":"BFbmt2016321_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2141.2004.05331.x","volume":"128","author":"T Feuchtinger","year":"2005","unstructured":"Feuchtinger T, L\u00fccke J, Hamprecht K, Richard C, Handgretinger R, Schumm M et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2005; 128: 503\u2013509.","journal-title":"Br J Haematol"},{"key":"BFbmt2016321_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.virol.2006.01.024","volume":"350","author":"J Tang","year":"2006","unstructured":"Tang J, Olive M, Pulmanausahakul R, Schnell M, Flomenberg N, Eisenlohr L et al. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology 2006; 350: 312\u2013322.","journal-title":"Virology"},{"key":"BFbmt2016321_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3324\/haematol.11279","volume":"92","author":"M Robin","year":"2007","unstructured":"Robin M, Marque-Juillet S, Scieux C, De Latour RP, Ferry C, Rocha V et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcome. Haematologica 2007; 92: 1254\u20131257.","journal-title":"Haematologica"},{"key":"BFbmt2016321_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bbmt.2012.01.013","volume":"18","author":"T Watson","year":"2012","unstructured":"Watson T, MacDonald D, Song X, Bromwich K, Campos J, Sande J et al. Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2012; 18: 1227\u20131234.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016321_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/jmv.23285","volume":"84","author":"C Henke-Gendo","year":"2012","unstructured":"Henke-Gendo C, Ganzenmueller T, Kluba J, Harste G, Raggub L, Heim A . Improved quantitative PCR protocols for adenovirus and CMV with an internal inhibition control system and automated nucleic acid isolation. J Med Virol 2012; 84: 890\u2013896.","journal-title":"J Med Virol"},{"key":"BFbmt2016321_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bbmt.2013.11.009","volume":"20","author":"M Mynarek","year":"2014","unstructured":"Mynarek M, Ganzenmueller T, Mueller-Heine A, Mielke C, Gonnermann A, Beier R et al. Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program. Biol Blood Marrow Transplant 2014; 20: 250\u2013256.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016321_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/leu.2010.4","volume":"24","author":"T Lion","year":"2010","unstructured":"Lion T, Kosulin K, Landlinger C, Rauch M, Preuner S, Jugovic D et al. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010; 24: 706\u2013714.","journal-title":"Leukemia"},{"key":"BFbmt2016321_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.bmt.1703798","volume":"31","author":"P Ljungman","year":"2003","unstructured":"Ljungman P, Ribaud P, Eyrich M, Matthes-Martin S, Einsele H, Bleakley M et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003; 31: 481\u2013486.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016321_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","volume":"134","author":"T Feuchtinger","year":"2006","unstructured":"Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134: 64\u201376.","journal-title":"Br J Haematol"},{"key":"BFbmt2016321_CR15","doi-asserted-by":"publisher","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","volume":"6","author":"A Papadopoulou","year":"2014","unstructured":"Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, Liu H, Martinez C et al. Activity of broad-spectrum T Cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med 2014; 6: 242ra83.","journal-title":"Sci Transl Med"},{"issue":"Suppl 1","key":"BFbmt2016321_CR16","first-page":"S4","volume":"3","author":"B Maecker-Kolhoff","year":"2015","unstructured":"Maecker-Kolhoff B, Eiz-Vesper B . Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation. Ann Transl Med 2015; 3 (Suppl 1): S4.","journal-title":"Ann Transl Med"},{"key":"BFbmt2016321_CR17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/tid.12318","volume":"16","author":"K Terasako-Saito","year":"2014","unstructured":"Terasako-Saito K, Nakasone H, Tanaka Y, Yamazaki R, Sato M, Sakamoto K et al. Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2014; 16: 930\u2013940.","journal-title":"Transpl Infect Dis"},{"key":"BFbmt2016321_CR18","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bbmt.2013.07.015","volume":"19","author":"C Sukdolak","year":"2013","unstructured":"Sukdolak C, Tischer S, Dieks D, Figueiredo C, Goudeva L, Heuft HG et al. CMV-, EBV- and ADV-specific T cell immunity: Screening and monitoring of potential third-party donors to improve post-transplantation outcome. Biol Blood Marrow Transplant 2013; 19: 1480\u20131492.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016321_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/JVI.01689-07","volume":"82","author":"AM Leen","year":"2008","unstructured":"Leen AM, Christin A, Khalil M, Weiss H, Gee AP, Brenner MK et al. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol 2008; 82: 546\u2013554.","journal-title":"J Virol"},{"key":"BFbmt2016321_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/tid.12101","volume":"15","author":"S Borchers","year":"2013","unstructured":"Borchers S, Weissinger EM, Pabst B, Ganzenmueller T, Dammann E, Luther S et al. Expansion of recipient-derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation. Transpl Infect Dis 2013; 15: 627\u2013633.","journal-title":"Transpl Infect Dis"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016321.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016321","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016321.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:11:09Z","timestamp":1648062669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016321"}},"subtitle":["-specific T cells promote HAdV control after allogeneic hematopoietic stem cell transplantation"],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFbmt2016321"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.321","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]},"assertion":[{"value":"9 January 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}